Mycoplasma testing of cell substrates and biologics: Review of alternative non-microbiological techniques

Molecular and Cellular Probes

Volumn 25, Issue 2-3, 2011, Pages 69-77

  Volokhov, Dmitriy V ^a   Graham, Laurie J ^b   Brorson, Kurt A ^b   Chizhikov, Vladimir E ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Biologics; Cell substrates; Detection; Mycoplasma; NAT assays

Indexed keywords

NUCLEIC ACID; TOLL LIKE RECEPTOR 2;

ACHOLEPLASMA; CELL CULTURE; CELL LINE; MICROARRAY ANALYSIS; MYCOPLASMA; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

DNA, BACTERIAL; HEK293 CELLS; HUMANS; MYCOPLASMA; MYCOPLASMA INFECTIONS; POLYMERASE CHAIN REACTION; RNA, BACTERIAL; SENSITIVITY AND SPECIFICITY;

ACHOLEPLASMA; MYCOPLASMA; MYCOPLASMATALES;

EID: 79955479502     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2011.01.002     Document Type: Review

References (78)

1. Razin S., Yogev D., Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998, 62:1094-1156.
2. Maniloff J. Phylogeny of mycoplasmas. Mycoplasmas: molecular biology and pathogenesis 1992, 549-559. American Society for Microbiology, Washington, DC. J. Maniloff, R.N. McElhaney, L.R. Finch, J.B. Baseman (Eds.).
3. Razin S. Structure and function in mycoplasma. Annu Rev Microbiol 1969, 23:317-356.
4. Miles R.J. Catabolism in mollicutes. J Gen Microbiol 1992, 138:1773-1783.
5. Messick J.B. Hemotrophic mycoplasmas (hemoplasmas): a review and new insights into pathogenic potential. Vet Clin Pathol 2004, 33:2-13.
6. Identification and treatment of pathogenic mycoplasmas. Mycoplasmas: molecular biology and pathogenesis 1992, American Society for Microbiology, Washington, DC. J. Maniloff, R.N. McElhaney, L.R. Finch, J.B. Baseman (Eds.).
7. Rottem S., Barile M.F. Beware of mycoplasmas. Trends Biotechnol 1993, 11:143-151.
8. EP.6.1 (2008) European pharmacopoeia 6.1; 2008.
9. FDA (1993) Food and Drug Administration. Center for Biologics Evaluation and Research. Points to consider in " Characterization of cell lines used to produce biologicals." Rockville, MD: US Department of Health and Human Services; 1993.
10. FDA (2010) Food and Drug Administration. Center for Biologics Evaluation and Research. Guidance for Industry: " Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications." Rockville, MD: US Department of Health and Human Services; 2010.
11. ICH (1997) Q5D: Derivation and characterization of cell substrates used for production of biotechnological/biological products. Geneva, Switzerland: International Committee on Harmonization; 1993.
12. Code of Federal Regulations (2009). Title 21, §610.30.
13. United States Pharmacopeia (2010).
14. Guthertz L.S., Griffith M.E., Ford E.G., Janda J.M., Midura T.F. Quality control of individual components used in Middlebrook 7H10 medium for mycobacterial susceptibility testing. J Clin Microbiol 1988, 26:2338-2342.
15. Windsor D., Windsor H. Quality-control testing of mycoplasma medium. Methods Mol Biol 1998, 104:61-67.
16. Polak-Vogelzang A.A., de Haan H.H., Borst J. Comparison of various atmospheric conditions for isolation and subcultivation of Mycoplasma hyorhinis from cell cultures. Antonie Van Leeuwenhoek 1983, 49:31-40.
17. McGarrity G.J., Sarama J., Vanaman V. Factors influencing microbiological assay of cell-culture mycoplasma. In Vitro 1979, 15:73-81.
18. Raccach M., Rottem S., Razin S. Survival of frozen mycoplasmas. Appl Microbiol 1975, 30:167-171.
19. Cheng H.S., Shen C.W., Wang S.R. Effect of storage conditions on detection of mycoplasma in biopharmaceutical products. In Vitro Cell Dev Biol Anim 2007, 43:113-119.
20. Milne C., Daas A. Establishment of European pharmacopoeia Mycoplasma reference strains. Pharmeuropa Bio 2006, 2006:57-72.
21. Mullis K.B., Faloona F.A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987, 155:335-350.
22. Razin S. DNA probes and PCR in diagnosis of mycoplasma infections. Mol Cell Probes 1994, 8:497-511.
23. Uphoff C.C., Drexler H.G. Detecting Mycoplasma contamination in cell cultures by polymerase chain reaction. Methods Mol Med 2004, 88:319-326.
24. Stakenborg T., Vicca J., Verhelst R., Butaye P., Maes D., Naessens A., et al. Evaluation of tRNA gene PCR for identification of mollicutes. J Clin Microbiol 2005, 43:4558-4566.
25. van Kuppeveld F.J., Johansson K.E., Galama J.M., Kissing J., Bolske G., van der Logt J.T., et al. Detection of mycoplasma contamination in cell cultures by a mycoplasma group-specific PCR. Appl Environ Microbiol 1994, 60:149-152.
26. Asarnow D., Warford A., Fernandez L., Hom J., Sandhu G., Candichoy Z., et al. Validation and international regulatory experience for a mycoplasma touchdown PCR assay. Biologicals 2010, 38:224-231.
27. Deutschmann S.M., Kavermann H., Knack Y. Validation of a NAT-based Mycoplasma assay according European Pharmacopoeia. Biologicals 2010, 38:238-248.
28. Eldering J.A., Felten C., Veilleux C.A., Potts B.J. Development of a PCR method for mycoplasma testing of Chinese hamster ovary cell cultures used in the manufacture of recombinant therapeutic proteins. Biologicals 2004, 32:183-193.
29. Zhi Y., Mayhew A., Seng N., Takle G.B. Validation of a PCR method for the detection of mycoplasmas according to European Pharmacopoeia section 2.6.7. Biologicals 2010, 38:232-237.
30. Birch L., Dawson C.E., Cornett J.H., Keer J.T. A comparison of nucleic acid amplification techniques for the assessment of bacterial viability. Lett Appl Microbiol 2001, 33:296-301.
31. Keer J.T., Birch L. Molecular methods for the assessment of bacterial viability. J Microbiol Methods 2003, 53:175-183.
32. Stormer M., Vollmer T., Henrich B., Kleesiek K., Dreier J. Broad-range real-time PCR assay for the rapid identification of cell-line contaminants and clinically important mollicute species. Int J Med Microbiol 2009, 299:291-300.
33. Peredeltchouk M., Wilson David S.A., Bhattacharya B., Volokhov D.V., Chizhikov V. Detection of mycoplasma contamination in cell substrates using reverse transcription-PCR assays. J Appl Microbiol 2011, 110(1):54-60.
34. Ovyn C., van Strijp D., Ieven M., Ursi D., van Gemen B., Goossens H. Typing of Mycoplasma pneumoniae by nucleic acid sequence-based amplification, NASBA. Mol Cell Probes 1996, 10:319-324.
35. Loens K., Ursi D., Ieven M., van Aarle P., Sillekens P., Oudshoorn P., et al. Detection of Mycoplasma pneumoniae in spiked clinical samples by nucleic acid sequence-based amplification. J Clin Microbiol 2002, 40:1339-1345.
36. Hardick J., Giles J., Hardick A., Hsieh Y.H., Quinn T., Gaydos C. Performance of the gen-probe transcription-mediated [corrected] amplification research assay compared to that of a multitarget real-time PCR for Mycoplasma genitalium detection. J Clin Microbiol 2006, 44:1236-1240.
37. Wroblewski J.K., Manhart L.E., Dickey K.A., Hudspeth M.K., Totten P.A. Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium. J Clin Microbiol 2006, 44:3306-3312.
38. Xu Y., Brorson K. An overview of quantitative PCR assays for biologicals: quality and safety evaluation. Dev Biol (Basel) 2003, 113:89-98.
39. Ishikawa Y., Kozakai T., Morita H., Saida K., Oka S., Masuo Y. Rapid detection of mycoplasma contamination in cell cultures using SYBR Green-based real-time polymerase chain reaction. In Vitro Cell Dev Biol Anim 2006, 42:63-69.
40. Arya M., Shergill I.S., Williamson M., Gommersall L., Arya N., Patel H.R. Basic principles of real-time quantitative PCR. Expert Rev Mol Diagn 2005, 5:209-219.
41. Schlesinger J., Tonjes M., Schueler M., Zhang Q., Dunkel I., Sperling S.R. Evaluation of the LightCycler 1536 Instrument for high-throughput quantitative real-time PCR. Methods 2010, 50:S19-S22.
42. Harasawa R., Mizusawa H., Fujii M., Yamamoto J., Mukai H., Uemori T., et al. Rapid detection and differentiation of the major mycoplasma contaminants in cell cultures using real-time PCR with SYBR Green I and melting curve analysis. Microbiol Immunol 2005, 49:859-863.
43. Lawrence B., Bashiri H., Dehghani H. Cross comparison of rapid mycoplasma detection platforms. Biologicals 2010, 38:218-223.
44. Ault G.S., Ryschkewitsch C.F., Stoner G.L. Type-specific amplification of viral DNA using touchdown and hot start PCR. J Virol Methods 1994, 46:145-156.
45. Rose P., Harkin J.M., Hickey W.J. Competitive touchdown PCR for estimation of Escherichia coli DNA recovery in soil DNA extraction. J Microbiol Methods 2003, 52:29-38.
46. Hecker K.H., Roux K.H. High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR. Biotechniques 1996, 20:478-485.
47. Don R.H., Cox P.T., Wainwright B.J., Baker K., Mattick J.S. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991, 19:4008.
48. Marois C., Savoye C., Kobisch M., Kempf I. A reverse transcription-PCR assay to detect viable Mycoplasma synoviae in poultry environmental samples. Vet Microbiol 2002, 89:17-28.
49. Grondahl B., Puppe W., Hoppe A., Kuhne I., Weigl J.A., Schmitt H.J. Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study. J Clin Microbiol 1999, 37:1-7.
50. Ortiz J.O., Forster F., Kurner J., Linaroudis A.A., Baumeister W. Mapping 70S ribosomes in intact cells by cryoelectron tomography and pattern recognition. J Struct Biol 2006, 156:334-341.
51. van Kuppeveld F.J., van der Logt J.T., Angulo A.F., van Zoest M.J., Quint W.G., Niesters H.G., et al. Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification. Appl Environ Microbiol 1992, 58:2606-2615.
52. Matsuda K., Tsuji H., Asahara T., Kado Y., Nomoto K. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 2007, 73:32-39.
53. Cenciarini-Borde C., Courtois S., La Scola B. Nucleic acids as viability markers for bacteria detection using molecular tools. Future Microbiol 2009, 4:45-64.
54. Kong H., Volokhov D.V., George J., Ikonomi P., Chandler D., Anderson C., et al. Application of cell culture enrichment for improving the sensitivity of mycoplasma detection methods based on nucleic acid amplification technology (NAT). Appl Microbiol Biotechnol 2007, 77:223-232.
55. Volokhov D.V., George J., Liu S.X., Ikonomi P., Anderson C., Chizhikov V. Sequencing of the intergenic 16S-23S rRNA spacer (ITS) region of Mollicutes species and their identification using microarray-based assay and DNA sequencing. Appl Microbiol Biotechnol 2006, 71:680-698.
56. Jang H., Kim H., Kang B., Kim C., Park H. Oligonucleotide array-based detection and genotyping of mollicutes (Acholeplasma, Mycoplasma, and Ureaplasma). J Microbiol Biotechnol 2009, 19:265-270.
57. Roth S.B., Jalava J., Ruuskanen O., Ruohola A., Nikkari S. Use of an oligonucleotide array for laboratory diagnosis of bacteria responsible for acute upper respiratory infections. J Clin Microbiol 2004, 42:4268-4274.
58. Onions D., Kolman J. Massively parallel sequencing, a new method for detecting adventitious agents. Biologicals 2010, 38:377-380.
59. Victoria J.G., Wang C., Jones M.S., Jaing C., McLoughlin K., Gardner S., et al. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 2010, 84:6033-6040.
60. Li K., Venter E., Yooseph S., Stockwell T.B., Eckerle L.D., Denison M.R., et al. ANDES: statistical tools for the ANalyses of DEep sequencing. BMC Res Notes 2010, 3:199.
61. Manske H.M., Kwiatkowski D.P. LookSeq: a browser-based viewer for deep sequencing data. Genome Res 2009, 19:2125-2132.
62. Brown D.R., Whitcomb R.F., Bradbury J.M. Revised minimal standards for description of new species of the class Mollicutes (division Tenericutes). Int J Syst Evol Microbiol 2007, 57:2703-2719.
63. Davis J., Cassell G.H., Gambill G., Cox N., Watson H., Davidson M. Diagnosis of murine mycoplasmal infections by enzyme-linked immunosorbent assay (ELISA). Isr J Med Sci 1987, 23:717-722.
64. Lin J.S. Human mycoplasmal infections: serologic observations. Rev Infect Dis 1985, 7:216-231.
65. Citti C., Nouvel L.X., Baranowski E. Phase and antigenic variation in mycoplasmas. Future Microbiol 2010, 5:1073-1085.
66. Rosengarten R., Wise K.S. Phenotypic switching in mycoplasmas: phase variation of diverse surface lipoproteins. Science 1990, 247:315-318.
67. Pollack J.D., Williams M.V., McElhaney R.N. The comparative metabolism of the mollicutes (Mycoplasmas): the utility for taxonomic classification and the relationship of putative gene annotation and phylogeny to enzymatic function in the smallest free-living cells. Crit Rev Microbiol 1997, 23:269-354.
68. Pollack J.D., Merola A.J., Platz M., Booth R.L. Respiration-associated components of Mollicutes. J Bacteriol 1981, 146:907-913.
69. Van Demark P.J. Respiratory pathways in the mycoplasma. Ann N Y Acad Sci 1967, 143:77-84.
70. Mariotti E., Mirabelli P., Di Noto R., Fortunato G., Salvatore F. Rapid detection of mycoplasma in continuous cell lines using a selective biochemical test. Leuk Res 2008, 32:323-326.
71. Volokhov D.V., Kong H., George J., Anderson C., Chizhikov V.E. Biological enrichment of Mycoplasma agents by cocultivation with permissive cell cultures. Appl Environ Microbiol 2008, 74:5383-5391.
72. Huang L.Y., Dumontelle J.L., Zolodz M., Deora A., Mozier N.M., Golding B. Use of toll-like receptor assays to detect and identify microbial contaminants in biological products. J Clin Microbiol 2009, 47:3427-3434.
73. Punyapornwithaya V., Fox L.K., Gay G.M., Hancock D.D., Alldredge J.R. Short communication: the effect of centrifugation and resuspension on the recovery of Mycoplasma species from milk. J Dairy Sci 2009, 92:4444-4447.
74. Lehmann D., Jouette S., Olivieri F., Laborde S., Rofel C., Simon E., et al. Novel sample preparation method for molecular detection of Mollicutes in cell culture samples. J Microbiol Methods 2009, 80:183-189.
75. Laborde S., Degrave A., Lehmann D., Jouette S., Rofel C., Muller T., et al. Detection of Mollicutes in bioreactor samples by real-time transcription-mediated amplification. Lett Appl Microbiol 2010, 50:633-638.
76. Knezevic I., Stacey G., Petricciani J., Sheets R. Evaluation of cell substrates for the production of biologicals: revision of WHO recommendations. Biologicals 2010, 38:162-169. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.
77. PDA. Alternative methods for mycoplasma testing. Bethesda, MD: Parenteral Drug Association, Inc.; 2010.
78. FDA. Guidance for industry: Q9 quality risk management Rockville, MD: U.S. Department of Health and Human Services; 2006. http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm128053.pdf.